Georgia Ramantani
Overview
Explore the profile of Georgia Ramantani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
113
Citations
1158
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Simma L, Kammerl A, Ramantani G
Eur J Pediatr
. 2025 Mar;
184(3):231.
PMID: 40053132
Conclusion: Despite some implementation challenges, pocEEG has shown sufficient accuracy for clinical use. Further research should focus on optimizing EEG montages, refining interpretation, and assessing its impact on patient outcomes....
2.
Disse S, Kupper H, Bock A, Korenke G, Ramantani G, Weidner B, et al.
Eur J Paediatr Neurol
. 2025 Feb;
54:200-209.
PMID: 39986237
Background: Sturge-Weber Syndrome (SWS) is a capillary-venous malformation which includes the brain (leptomeningeal venous capillary malformation), the eye (choroidal angioma) and the skin (facial portwine birthmark, FPB). Structural epilepsy, glaucoma...
3.
Karatza P, Cserpan D, Moser K, Lo Biundo S, Sarnthein J, Ramantani G
Epilepsia
. 2024 Dec;
PMID: 39740252
Objective: This study aimed to investigate two key aspects of scalp high-frequency oscillations (HFOs) in pediatric focal lesional epilepsy: (1) the stability of scalp HFO spatial distribution across consecutive nights,...
4.
Cerulli Irelli E, Fanella M, Chaumette B, Putotto C, Mignot C, Mazzeo A, et al.
Epilepsia
. 2024 Dec;
66(3):859-869.
PMID: 39718534
Objective: This study was undertaken to characterize the clinical and genetic features of patients with 22q11.2 deletion syndrome (22q11.2DS) and generalized epilepsy compared with 22q11.2DS individuals without epilepsy. Methods: This...
5.
Falsaperla R, Sortino V, Kluger G, Herberhold T, Ruegger A, Striano P, et al.
Epilepsia Open
. 2024 Dec;
10(1):31-39.
PMID: 39641282
Glucose transporter type 1 deficiency syndrome (GLUT1DS) commonly presents with early-onset epilepsy that often resists conventional pharmacological treatment. Ketogenic diet therapy (KDT) is the preferred approach to address the underlying...
6.
Ramantani G, Gennari A, Holthausen H
Epilepsy Behav
. 2024 Nov;
162:110173.
PMID: 39615263
Cerebral infections are a common cause of structural focal epilepsy, particularly in developing countries, where the risk of unprovoked seizures is higher and is related to brain lesions and status...
7.
Gennari A, Bicciato G, Lo Biundo S, Kottke R, Cserpan D, Tuura OGorman R, et al.
Radiol Med
. 2024 Nov;
130(1):63-73.
PMID: 39531157
Purpose: Arterial spin labeling (ASL), a noninvasive magnetic resonance (MRI) perfusion sequence, holds promise in the presurgical evaluation of pediatric lesional epilepsy patients, including those with low-grade epilepsy-associated tumors (LEATs)....
8.
Gennari A, Waelti S, Schwyzer M, Treyer V, Rossi A, Sartoretti T, et al.
Eur J Nucl Med Mol Imaging
. 2024 Oct;
52(2):574-585.
PMID: 39352423
Purpose: To assess the trends in administered 2-[F]fluoro-2-deoxy-D-glucose ([F]FDG) doses, computed tomography (CT) radiation doses, and image quality over the last 15 years in children with drug-resistant epilepsy (DRE) undergoing...
9.
10.
Ramantani G, Wirrell E
Epilepsy Behav
. 2024 Aug;
159:109985.
PMID: 39181112
Developmental and epileptic encephalopathies (DEEs) present significant treatment challenges due to frequent, drug-resistant seizures and comorbidities that impact quality of life. DEEs include both developmental encephalopathy from underlying pathology and...